InvAscent is the investment advisor to EILSF (Fund I) and India Life Sciences Fund II who provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.

EILSF (Fund I) made 8 investments during the period 2007-12 including a specialty generic injectables company with US FDA approved manufacturing facilities; a US FDA approved manufacturer of specialized medicines for treating Central Nervous System disorders; India’s largest producer of Vitamin D3; India’s largest network of cancer hospitals, and one of India’s Top 3 private ophthalmology networks.

The Investment Advisor is comprised of individuals with deep domain expertise and a track record of value creation in pharma and healthcare industries. Team members based out of Hyderabad and San Francisco are closely involved in assisting portfolio companies execute their business plans.